IDEAYA Biosciences Inc (NASDAQ:IDYA)
| 22.13 Delayed Data As of Dec 03 |  -0.38 / -1.69%Today’s Change | 12.40 Today|||52-Week Range 28.00 | +58.07% Year-to-Date |
Latest IDYA News | Press Releases
No recent news for IDEAYA Biosciences Inc.
Today’s Trading
| Previous close | 22.51 |
| Today’s open | 22.11 |
| Day’s range | 21.65 - 22.49 |
| Volume | 9,628 |
| Average volume (3 months) | 311,318 |
| Market cap | $861.6M |
Data as of 3:59pm ET, 12/03/2021
Growth & Valuation
| Earnings growth (last year) | +58.46% |
| Earnings growth (this year) | +12.77% |
| Earnings growth (next 5 years) | +18.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 17.71 |
| Price/Book | 3.33 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ZYMEZymeworks Inc | -1.78 | -8.79% |
| ---- | ||
| KURAKura Oncology Inc | -1.12 | -8.28% |
| KNSAKiniksa Pharmaceutic... | -0.04 | -0.34% |
Data as of 4:00pm ET, 12/03/2021
Financials
| Next reporting date | March 29, 2022 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $19.5M |
| Annual profit (last year) | -$34.5M |
| Net profit margin | -176.55% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
